Skip to main content
NVDA-0.21%AAPL+1.14%GOOGL-2.28%MSFT+0.04%AMZN-0.03%TSM-0.83%SPCX-3.86%AVGO-1.13%META+1.42%TSLA-0.41%SKHY+7.05%MU-1.33%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.44%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.53%0005.HK-0.78%HSBA.L-1.34%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.21%CHFJPY-1.68%USDJPY-1.63%AUDJPY-1.57%EURJPY-1.44%CADJPY-1.42%GBPJPY-1.37%GBPNZD+0.84%EURNZD+0.81%NZDCAD-0.80%AUDNZD+0.67%NZDUSD-0.61%NZDCHF-0.57%GBPTRY+0.41%GBPHKD+0.32%EURNOK+0.30%GBPCHF+0.29%GBPMXN-0.28%CHFNOK+0.27%USDNOK+0.27%EURZAR+0.27%GBPZAR+0.27%GBPUSD+0.26%EURCHF+0.24%USDZAR+0.24%CADCHF+0.23%USDCAD-0.20%EURUSD+0.19%NZDMXN+0.18%NZDSGD+0.18%GBPAUD+0.18%NOKJPY-0.17%AUDCAD-0.17%AUDDKK-0.16%USDILS+0.16%EURAUD+0.14%AUDNOK+0.13%AUDCHF+0.11%USDTRY+0.11%USDTHB+0.10%EURCZK-0.09%EURSGD+0.08%AUDSGD-0.08%GBPSGD+0.08%USDMXN+0.08%EURSEK+0.08%PLNJPY+0.07%AUDUSD+0.06%EURPLN+0.06%USDSGD+0.06%CHFSGD+0.06%USDCHF+0.05%CHFSEK+0.05%USDSEK+0.05%EURGBP-0.04%SGDJPY+0.04%USDCOP-0.04%GBPCAD+0.04%USDPLN+0.03%USDCNH-0.03%USDDKK-0.02%EURCNH+0.02%EURHKD+0.02%USDHKD+0.01%EURCAD-0.01%EURDKK0.00%HG1-2.54%COFFEE-2.07%SUGAR+1.96%COCOA-1.52%XPTUSD-1.50%COTTON+1.27%XAGUSD-1.06%GAGUSD-1.06%S1+0.54%C1+0.52%USOIL+0.40%UKOIL+0.16%BTCUSD-0.38%ETHUSD+0.10%USDTUSD-0.08%XRPUSD-1.15%SOLUSD-0.34%TRXUSDT+0.45%ZECUSDT-1.29%DOGEUSD-1.20%XMRUSDT-1.28%LINKUSD+0.15%XLMUSD-0.90%BCHUSDT-1.77%LTCUSD-1.46%UNIUSD-1.81%TONUSD+24.88%HBARUSDT-1.21%SUIUSD-1.19%TAOUSDT-0.92%AAVEUSD-1.61%DOTUSDT-2.01%ICPUSDT-0.50%ONDOUSDT-1.73%WLDUSDT-1.47%ATOMUSDT-2.33%ARBUSDT+0.29%JUPUSDT-2.10%INJUSDT-2.29%STXUSDT-2.70%FETUSDT-2.09%TIAUSDT-0.60%SEIUSDT-1.80%PYTHUSDT-0.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.14%OPUSDT-1.99%POLUSDT-3.70%IOTAUSDT-1.93%AXSUSDT-1.71%FARTCOINUSDT-1.28%EOSUSDT+0.43%DYDXUSDT-0.47%ORDIUSDT+0.53%GALAUSDT-3.09%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.21%AAPL+1.14%GOOGL-2.28%MSFT+0.04%AMZN-0.03%TSM-0.83%SPCX-3.86%AVGO-1.13%META+1.42%TSLA-0.41%SKHY+7.05%MU-1.33%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.44%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.53%0005.HK-0.78%HSBA.L-1.34%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.21%CHFJPY-1.68%USDJPY-1.63%AUDJPY-1.57%EURJPY-1.44%CADJPY-1.42%GBPJPY-1.37%GBPNZD+0.84%EURNZD+0.81%NZDCAD-0.80%AUDNZD+0.67%NZDUSD-0.61%NZDCHF-0.57%GBPTRY+0.41%GBPHKD+0.32%EURNOK+0.30%GBPCHF+0.29%GBPMXN-0.28%CHFNOK+0.27%USDNOK+0.27%EURZAR+0.27%GBPZAR+0.27%GBPUSD+0.26%EURCHF+0.24%USDZAR+0.24%CADCHF+0.23%USDCAD-0.20%EURUSD+0.19%NZDMXN+0.18%NZDSGD+0.18%GBPAUD+0.18%NOKJPY-0.17%AUDCAD-0.17%AUDDKK-0.16%USDILS+0.16%EURAUD+0.14%AUDNOK+0.13%AUDCHF+0.11%USDTRY+0.11%USDTHB+0.10%EURCZK-0.09%EURSGD+0.08%AUDSGD-0.08%GBPSGD+0.08%USDMXN+0.08%EURSEK+0.08%PLNJPY+0.07%AUDUSD+0.06%EURPLN+0.06%USDSGD+0.06%CHFSGD+0.06%USDCHF+0.05%CHFSEK+0.05%USDSEK+0.05%EURGBP-0.04%SGDJPY+0.04%USDCOP-0.04%GBPCAD+0.04%USDPLN+0.03%USDCNH-0.03%USDDKK-0.02%EURCNH+0.02%EURHKD+0.02%USDHKD+0.01%EURCAD-0.01%EURDKK0.00%HG1-2.54%COFFEE-2.07%SUGAR+1.96%COCOA-1.52%XPTUSD-1.50%COTTON+1.27%XAGUSD-1.06%GAGUSD-1.06%S1+0.54%C1+0.52%USOIL+0.40%UKOIL+0.16%BTCUSD-0.38%ETHUSD+0.10%USDTUSD-0.08%XRPUSD-1.15%SOLUSD-0.34%TRXUSDT+0.45%ZECUSDT-1.29%DOGEUSD-1.20%XMRUSDT-1.28%LINKUSD+0.15%XLMUSD-0.90%BCHUSDT-1.77%LTCUSD-1.46%UNIUSD-1.81%TONUSD+24.88%HBARUSDT-1.21%SUIUSD-1.19%TAOUSDT-0.92%AAVEUSD-1.61%DOTUSDT-2.01%ICPUSDT-0.50%ONDOUSDT-1.73%WLDUSDT-1.47%ATOMUSDT-2.33%ARBUSDT+0.29%JUPUSDT-2.10%INJUSDT-2.29%STXUSDT-2.70%FETUSDT-2.09%TIAUSDT-0.60%SEIUSDT-1.80%PYTHUSDT-0.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.14%OPUSDT-1.99%POLUSDT-3.70%IOTAUSDT-1.93%AXSUSDT-1.71%FARTCOINUSDT-1.28%EOSUSDT+0.43%DYDXUSDT-0.47%ORDIUSDT+0.53%GALAUSDT-3.09%NOTUSDT-0.68%RONINUSDT-0.71%
IN

Innoviva, Inc. (INVA)

NASDAQ • Healthcare

$21.13
-$0.21 (-1.0%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$21.16
Day Range$20.77 - $21.41
Avg. Volume (3M)616.7K
Market Cap$1.5B
P/E Ratio4.3
52 Week Range
$16.52$25.15
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$119.5M100%
Gross Profitminus cost of goods$90.6M76%
Operating Incomeminus R&D and overhead$50.8M43%

In plain terms: out of every $100 in revenue, Innoviva, Inc. currently loses $70.

Fundamentals & Financials

Revenue (TTM)
$443.4M
Net Income (TTM)
$357.2M
EPS (TTM)
$4.87
ROA (TTM)
20.98%
Current Ratio
16.01
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+470.6%Q1 2026$1.94
+2.3%Q2 2026$0.44
+161.5%Q3 2026$1.14
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Innoviva, Inc.

Innoviva, Inc. is a NASDAQ-listed biotechnology company that earns royalty-based revenue from partnered respiratory medicines. The company recorded $425.1 million of revenue in FY2025. Formerly known as Theravance, Inc., it sits in the healthcare sector and centers its economics on products commercialized through a collaboration with Glaxo Group Limited.

Name
Innoviva, Inc.
CEO
Pavel Raifeld
Website
www.inva.com
Industry
Healthcare
Year Founded
1996
Employees
159

Today's Snapshot

AI-generated

INVA closed 1% lower at 21.13, while its sector was flat.

Trading Volume

Above 10d avg 677.9K

835.7K

vs S&P 500 Today

Underperforming Market

-0.56%

Updated: September 9, 2026 at 20:29 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
INVA shows a mildly bearish tilt with the stock trading near $21.1 and several medium- and long-term moving averages sitting above the market, keeping broader bias negative. Momentum and MACD are essentially neutral and the RSI is near the midline, reflecting limited directional conviction, while ADX is very low and confirms a weak trend. Average true range signals modest intraday movement, and on-balance volume is constructive, implying some accumulation despite weak price action. The classic pivot lies slightly above the current level. Technical takeaway: Overall bias is bearish, driven by price beneath key averages amid weak trend strength.
All signals
  • EMA (5 indicators)$21.16 - $21.66
    Sell
  • RSI (14)48.54
    Neutral
  • Stochastic %K (14, 3, 3)60.88
    Neutral
  • MACD Level (12, 26)-0.02
    Neutral

Peers & Related Assets

DNTHDianthus Therapeutics, Inc.
$107.04-1.9%
ELVNEnliven Therapeutics, Inc.
$57.45-3.2%
RLAYRelay Therapeutics, Inc.
$18.66-2.4%
SNDXSyndax Pharmaceuticals, Inc.
$19.84-0.5%
INBXInhibrx Biosciences Inc.
$112.86-1.3%
MDXGMiMedx Group, Inc.
$4.68+0.2%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.